Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 10,987 | 25,842 | 6,826 | 5,446 | 3,238 |
| Cost of Goods | 1,346 | N/A | 15 | N/A | 0 |
| Gross Profit | 9,641 | 25,842 | 6,811 | 5,445 | 3,238 |
| Operating Expenses | 23,149 | 20,500 | 21,256 | 20,602 | 14,848 |
| Operating Income | -13,162 | 5,342 | -14,430 | -15,156 | -11,610 |
| Interest Expense | 1,241 | 1,306 | 1,315 | 1,314 | 1,217 |
| Other Income | -218 | 865 | 581 | 4,798 | 4,096 |
| Pre-tax Income | -14,621 | 4,901 | -15,164 | -11,672 | -8,731 |
| Net Income Continuous | -14,621 | 4,901 | -15,164 | -11,672 | -8,731 |
| Net Income | $-14,621 | $4,901 | $-15,164 | $-11,672 | $-8,731 |
| EPS Basic Total Ops | -0.20 | 0.07 | -0.21 | -0.16 | -0.12 |
| EPS Basic Continuous Ops | -0.20 | 0.07 | -0.21 | -0.15 | -0.12 |
| EPS Diluted Total Ops | -0.20 | 0.06 | -0.21 | -0.16 | -0.12 |
| EPS Diluted Continuous Ops | -0.20 | 0.06 | -0.21 | -0.15 | -0.12 |
| EBITDA(a) | $-12,817 | $5,767 | $-14,275 | $-14,856 | $-11,461 |